Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) FCF Margin (2020 - 2022)

Immuneering has reported FCF Margin over the past 3 years, most recently at 2597344.18% for Q4 2022.

  • Quarterly results put FCF Margin at 2597344.18% for Q4 2022, down 259246418.0% from a year ago — trailing twelve months through Sep 2023 was 10809489.45% (down 1080113559.0% YoY), and the annual figure for FY2022 was 14148.44%, down 1266227.0%.
  • FCF Margin for Q4 2022 was 2597344.18% at Immuneering, down from 28701.08% in the prior quarter.
  • Over the last five years, FCF Margin for IMRX hit a ceiling of 511.54% in Q3 2020 and a floor of 2597344.18% in Q4 2022.
  • Median FCF Margin over the past 3 years was 3378.13% (2021), compared with a mean of 265287.05%.
  • Biggest five-year swings in FCF Margin: crashed -136471bps in 2021 and later plummeted -259246418bps in 2022.
  • Immuneering's FCF Margin stood at 825.64% in 2020, then tumbled by -491bps to 4880.0% in 2021, then tumbled by -53124bps to 2597344.18% in 2022.
  • The last three reported values for FCF Margin were 2597344.18% (Q4 2022), 28701.08% (Q3 2022), and 10182.56% (Q2 2022) per Business Quant data.